Medroxyprogesterone and Nuwiq recombinant
Determining the interaction of Medroxyprogesterone and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: MedroxyPROGESTERone
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medroxyprogesterone-NuZole
- Medroxyprogesterone-Nuzyra
- Medroxyprogesterone-Nuzyra (Omadacycline Injection)
- Medroxyprogesterone-Nuzyra (Omadacycline Tablets)
- Medroxyprogesterone-Nuzyra Intravenous
- Medroxyprogesterone-Nuzyra oral/injection
- Nuwiq recombinant-Medroxyprogesterone Acetate
- Nuwiq recombinant-Medroxyprogesterone injection
- Nuwiq recombinant-Medroxyprogesterone Injection (400 mg/mL)
- Nuwiq recombinant-Medroxyprogesterone Injection (Intramuscular)
- Nuwiq recombinant-Medroxyprogesterone Injection (Subcutaneous)
- Nuwiq recombinant-Medroxyprogesterone Injection ER